Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Morgan E. Wagner
Observed name:
Morgan Wagner
Institution:
University of Connecticut
Observed institutions:
University of Connecticut,
Frederick National Laboratory for Cancer Research,
National Cancer Institute,
Leidos Biomedical Research Inc. (United States)
ORCID:
0000-0003-2848-2892
Observed ORCID:
0000-0003-2848-2892
OpenAlex ID:
A5049188516
RASopathy mutations provide functional insight into the BRAF cysteine-rich domain and reveal the importance of autoinhibition in BRAF regulation
2022
·
Russell Spencer-Smith
, Elizabeth M. Terrell
, et al.
·
Molecular Cell
·
43
RAS-dependent RAF-MAPK hyperactivation by pathogenic RIT1 is a therapeutic target in Noonan syndrome–associated cardiac hypertrophy
2023
·
Antonio Cuevas-Navarro
, Morgan Wagner
, et al.
·
Science Advances
·
34
PDF
The seventh international RASopathies symposium: Pathways to a cure—expanding knowledge, enhancing research, and therapeutic discovery
2022
·
Maria I. Kontaridis
, Amy E. Roberts
, et al.
·
American Journal of Medical Genetics Part A
·
16
PDF
Abstract 3889 Evaluating the Solution-State Dynamics of the Toxoplasma Gondii GTPase BipA
2026
·
Morgan Wagner
, Michael Griffith
, et al.
·
Journal of Biological Chemistry
An apicoplast-localized GTPase is essential for Toxoplasma gondii survival
2025
·
Michael B. Griffith
, Morgan E. Wagner
, et al.
·
mSphere
PDF
Abstract PR06: Germline RASopathy mutations provide insights into the differential regulation of RAF family kinases
2023
·
Russell Spencer-Smith
, Elizabeth M. Terrell
, et al.
·
Molecular Cancer Research
Show more works
View as search
Works count:
6
Citation count:
93
H-index:
3
I10-index:
3
Year
Topic
Type